Healthtech Startups
18,497 companies tagged Healthtech, with their investors and founders.
NKA Bio develops antibody-based medicines for critically ill and trauma patients to extend survival time during medical emergencies. The company's lead candidate, NKA01, is an anti-shock toxin antibody administered by emergency medical services to stabilize trauma patients and buy time for transport and surgical intervention.
2 investors
Nolla is developing a technology-driven, doctor-guided care system that helps users understand their health situation and decide what to do next. It is built by a team of doctors, engineers, and researchers focused on making healthcare more accessible and easier to navigate.
2 investors
Nonu provides a comprehensive hair loss treatment kit combining medical guidance, pharmaceuticals, and nutritional support for men experiencing hair loss. The offering integrates conventional medicine, Ayurveda, and nutrition-based approaches.
2 investors
Noora Health equips families and caregivers with health education and skills to support patient recovery in hospitals and at home. The organization works to improve health outcomes by training informal caregivers, primarily in hospital and post-discharge settings.
2 investors
Nordic is a healthcare technology consulting firm that helps healthcare organizations solve data fragmentation, workforce capacity challenges, cost pressures, operational bottlenecks, and technology gaps. The company provides consulting guidance, system modernization, and workflow optimization services to healthcare providers worldwide.
2 investors
Nordiq Products develops a medical monitoring device that uses an optical sensor to automatically calibrate to a patient's skin type and combines multiple sensors (sensor fusion) to track the same vital sign for more reliable results. The device supports modern connectivity for integration with external systems.
2 investors
Northernmost develops machines to preserve and transport human organs for transplant, including the NoMo Kidney Pump for continuous kidney perfusion from donor to recipient. The company builds medical devices for the organ transplant field.
2 investors
Northwind operates a telemedicine platform connecting patients with dermatologists for diagnosis and treatment of chronic skin conditions including psoriasis and atopic eczema, offering customized treatment plans and a line of proprietary topical medications with ongoing follow-up care.
2 investors
Nostopharma develops targeted nanodelivery technology and advanced molecular interventions for bone and soft tissue disorders, using precision medicine approaches to repurpose existing drugs. The company serves clinicians treating patients with conditions like heterotopic ossification and cartilage damage.
2 investors
NovaFlow is an AI-powered data analysis platform that automates bioinformatics workflows for life science researchers and biotech labs, transforming raw experimental data into publication-ready results in minutes using large language models and validated computational pipelines.
2 investors
NovalGen is a clinical-stage biotechnology company developing multi-specific biologics for oncology, autoimmune, haematological, and metabolic disorders using its proprietary AutoRegulation platform technology.
2 investors
NOVELDA develops Ultra-Wideband (UWB) short-range impulse radar sensors for detecting human presence in indoor environments, serving consumer electronics and smart building applications. The technology enables improved user experience and energy efficiency across various IoT and building automation use cases.
2 investors
Novellia is a health platform that consolidates fragmented medical records so patients can access a complete view of their health data and share it with care teams and researchers. It serves patients and their families seeking to manage and advocate for their own care.
2 investors
Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies. It serves patients and healthcare markets globally.
2 investors
Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer. The company focuses on patient-centered innovation in oncology.
2 investors
Novoflow provides a patient cancellation and no-show recovery system that integrates with existing EHR platforms to automatically identify, match, and contact patients to reschedule missed appointments.
2 investors
Novoron develops lipoprotein-receptor small molecule therapies aimed at repairing damage and degeneration of the brain and spinal cord, including treatments for proteinopathies and neuroregeneration following traumatic injury. The company focuses on drug discovery for neurological conditions such as neurodegeneration and cognitive decline.
2 investors
NowRx presents itself as a pharmacy service focused on fast, accurate medication delivery, alongside health content covering conditions, medicine, and wellness topics. The site combines a pharmacy offering with an informational blog for consumers.
2 investors
Nowwell is a company driving innovation in urology through research and product development. The organization brings together expertise in clinical science, product development, quality assurance, and strategy.
2 investors
NTx Bio develops proprietary cell-free synthetic biology platforms for on-demand, decentralized biomanufacturing of mRNA and proteins. The company serves drug developers and researchers seeking faster, scalable production of therapeutic molecules from concept to commercial manufacturing.
2 investors
NUA Surgical develops surgical medical devices focused on maternal and infant health, currently in pre-clinical development. The company has won maternal and infant health innovation and startup investment competitions in Ireland.
2 investors
Nuanced Health develops healthcare solutions, though the specific product focus is not detailed on this team page.
2 investors
Nuclivision develops AI software to enhance nuclear medicine imaging, enabling PET centers to increase capacity and reduce costs without replacing equipment. The platform serves clinical departments across Europe and the US.
2 investors
A specialty pharmaceutical company focused on developing and commercializing novel therapeutics for central nervous system conditions, serving patients and healthcare providers.
2 investors

















